Inspire Medical Systems (INSP) Accumulated Expenses (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Accumulated Expenses data on file, last reported at $47.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 38.55% year-over-year to $47.6 million; the trailing twelve-month figure through Mar 2026 stood at $47.6 million (up 38.55% YoY), and the FY2025 full-year result was $59.5 million, up 19.42% from the prior year.
• Accumulated Expenses declined to $47.6 million in Q1 2026, from $59.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $59.5 million in Q4 2025 to a low of $13.9 million in Q1 2022.
• A 5-year average of $35.2 million and a median of $34.3 million in 2025 frame the typical range for Accumulated Expenses.
• Peak annual rise in Accumulated Expenses reached 68.32% in 2023, while the deepest fall reached 3.37% in 2023.
• Tracing INSP's Accumulated Expenses over 5 years: stood at $34.3 million in 2022, then rose by 14.35% to $39.3 million in 2023, then rose by 26.86% to $49.8 million in 2024, then rose by 19.42% to $59.5 million in 2025, then fell by 20.04% to $47.6 million in 2026.
• Business Quant data shows INSP's Accumulated Expenses at $47.6 million in Q1 2026, $59.5 million in Q4 2025, and $51.6 million in Q3 2025.